Cellectis S.A. (CLLS) Earnings
NASDAQ·Healthcare·Biotechnology
$3.14
+2.79%
Mkt Cap $361.10M
EPS — Estimate vs Actual
Mkt Cap
$361.10M
P/E
—
Fwd P/E
—
P/S
3.98
Rev TTM
—
EPS TTM
-$0.68
NASDAQ·Healthcare·Biotechnology
$3.14
+2.79%
Mkt Cap $361.10M
Mkt Cap
$361.10M
P/E
—
Fwd P/E
—
P/S
3.98
Rev TTM
—
EPS TTM
-$0.68